Viruses and bacteria used in this study are indicated in Table S1 . Growth, quantification and verification of viral and bacterial cultures were performed by Zeptometrix (Buffalo, NY). Bocavirus (BoV) and Coronavirus (CoV) HKU1 could not be grown in culture. Instead, well-characterized clinical specimens were utilized and quantified in copies per ml by real-time PCR against a standard curve of synthetic template.
Residual clinical NPA specimens (stored frozen at −80°C) came from children younger than 18 years who had NPA collected for respiratory viral testing by direct fluorescent antibody (DFA) and culture at Primary Children's Medical Center (PCMC), Salt Lake City, UT between 2006 and 2008. Approximately half of the NPA specimens chosen for analysis were negative by DFA and viral culture. FilmArray testing was performed at both PCMC and ITI. PCR results were not used to inform clinical management or reported to microbiology technicians performing DFA and viral culture.
FilmArray data used for tuning the melt calling algorithm were acquired at sites performing beta testing of the instrument. The data used to validate the algorithm were acquired during clinical trials of the FilmArray system and RP pouch at the Medical University of South Carolina (Frederick S. Nolte, PhD), Detroit Medical Center (Hossein Salimnia, PhD), and Children's Medical Center of Dallas (Beverly Rogers, M.D.).
The institutional review boards of the University of Utah and PCMC approved this study and granted a waiver of informed consent because the patient samples were de-identified. All external clinical studies were performed with appropriate IRB approval. Data from these sites were de-identified before being sent to Idaho Technology.
Residual clinical NPA specimens (stored frozen at −80°C) came from children younger than 18 years who had NPA collected for respiratory viral testing by direct fluorescent antibody (DFA) and culture at Primary Children's Medical Center (PCMC), Salt Lake City, UT between 2006 and 2008. Approximately half of the NPA specimens chosen for analysis were negative by DFA and viral culture. FilmArray testing was performed at both PCMC and ITI. PCR results were not used to inform clinical management or reported to microbiology technicians performing DFA and viral culture.
FilmArray data used for tuning the melt calling algorithm were acquired at sites performing beta testing of the instrument. The data used to validate the algorithm were acquired during clinical trials of the FilmArray system and RP pouch at the Medical University of South Carolina (Frederick S. Nolte, PhD), Detroit Medical Center (Hossein Salimnia, PhD), and Children's Medical Center of Dallas (Beverly Rogers, M.D.).
The institutional review boards of the University of Utah and PCMC approved this study and granted a waiver of informed consent because the patient samples were de-identified. All external clinical studies were performed with appropriate IRB approval. Data from these sites were de-identified before being sent to Idaho Technology.
Full text: Click here